Hepatitis B Treatment Market – Antiviral Innovation and Screening Programs Drive Growth
The hepatitis B treatment market is expanding as awareness, screening, research investment, and healthcare access improve globally. The market was valued at USD 4.8 billion in 2024 and is projected to reach USD 8 billion by 2035, growing at a CAGR of 4.8%.wiseguyreports Antiviral drugs are the dominant treatment category, valued at USD 2.5 billion in 2024 and expected to reach USD 4 billion by...
0 Comments 0 Shares 6 Views 0 Reviews